3 Russell 2000 Companies We View with Prudence

Exploring Opportunities in the Russell 2000

The Russell 2000 index is renowned for its collection of smaller, high-growth companies, offering investors a chance to discover stocks with breakout potential. Yet, these firms often lack the stability and financial strength seen in larger corporations, making it essential to choose investments wisely.

Given the complexity of this segment, StockStory was developed to help investors distinguish promising stocks from those less likely to succeed. Below, we highlight three Russell 2000 companies that fall short, along with alternatives worth considering.

Rush Enterprises (RUSHA)

Market Capitalization: $4.83 billion

Based in Texas, Rush Enterprises (NASDAQ: RUSH.A) specializes in commercial truck services, offering sales, leasing, parts, and maintenance solutions for fleet operators.

Key Risks for RUSHA

• Sales have dropped by an average of 3.1% per year over the past two years, indicating ongoing challenges in its target markets.
• The company’s gross margin stands at 20.3%, highlighting elevated production expenses.
• Declining earnings per share over the last two years have raised concerns among investors, as stock performance often mirrors EPS trends over time.

Currently, Rush Enterprises trades at $63.42 per share, with a forward price-to-earnings ratio of 17.1.

NeoGenomics (NEO)

Market Capitalization: $1.04 billion

NeoGenomics (NASDAQ: NEO) operates a network of accredited laboratories in the US and UK, providing advanced cancer diagnostics, including genetic and molecular testing, as well as pathology consultations for medical professionals.

Why We’re Cautious About NEO

• Although revenue has grown over the past five years, new share issuances have offset these gains, resulting in a 3% annual decline in earnings per share.
• Negative returns on capital suggest that expansion efforts have not been profitable for the company.
• A high net-debt-to-EBITDA ratio of 6× could force NeoGenomics to seek additional funding under unfavorable conditions if the market worsens.

NeoGenomics is priced at $7.95 per share, with a forward P/E of 48.8.

DigitalBridge (DBRG)

Market Capitalization: $2.81 billion

DigitalBridge Group (NYSE: DBRG) transitioned from a traditional real estate investor to a global leader in digital infrastructure in 2021. The company manages investments and operates assets such as data centers, cell towers, fiber networks, and edge computing facilities.

Reasons to Reconsider DBRG

• Sales have plummeted by 68.3% annually over the past five years, reflecting significant difficulties in its core markets.
• Earnings per share have decreased by 14.1% each year for the last two years, which could negatively impact long-term stock performance.
• Ongoing losses may require DigitalBridge to issue more shares if credit markets tighten, potentially diluting shareholder value.

DigitalBridge is valued at $15.35 per share, with a forward P/E ratio of 2.2.

Preferred Stock Picks

Bonus: Top 6 Stocks to Watch This Week

The current market is quickly distinguishing high-quality stocks from overpriced ones, with AI-driven shifts impacting entire industries unexpectedly. In such a fast-moving environment, a simple list of good companies isn’t enough.

Our AI platform identified Palantir before its 1,662% surge, AppLovin ahead of its 753% rise, and Nvidia prior to its 1,178% climb. Every week, it highlights six new stocks that meet rigorous criteria.

Past selections from 2020 include well-known names like Nvidia, which delivered a 1,326% return between June 2020 and June 2025, and lesser-known companies such as Comfort Systems, which achieved a 782% five-year gain.